+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Prothrombin Complex Concentrate Market, By Type, By End-User, By Application, By Country: Trend Analysis, Competitive Market Share & Forecast, 2018-2028

  • PDF Icon

    Report

  • 170 Pages
  • August 2022
  • Region: Europe
  • Blueweave Consulting & Research Pvt Ltd
  • ID: 5647222

Europe Prothrombin Complex Concentrate Market to Reach USD 409.5 Million by 2028


Europe's prothrombin complex concentrate market is growing owing to increasing instances of warfarin-associated bleeding disorders, the frequency of coagulation factor disorders, and people's rising income levels coupled with factors like less time required to administer and several benefits over other alternative anticoagulation-reversal therapies such as Fresh Frozen Plasma.

A recent study revealed that the Europe prothrombin complex concentrate market was worth USD 197.1 million in 2021. The market is projected to grow at a CAGR of 11.2%, earning around USD 409.5 billion in revenues by 2028. The Europe prothrombin complex concentrate market is booming due to less administration time and several advantages over alternative anticoagulation-reversal therapies such as Fresh Frozen Plasma. Moreover, factors like an increase in warfarin-associated bleeding disorders, the frequency of coagulation factor disorders, and people's rising income levels propel the Europe prothrombin complex concentrate Market.

Growing Geriatric Populations In Europe Coupled With the Development Of Anticoagulation Clinics Will Open Up Market Opportunities


The continent's growing aging population is one new reason for boosting Europe's prothrombin complex concentrate industry. The UN Population Division's most recent statistics show that nearly 25% of Europeans are 60 years of age or older. Additionally, according to projections from the European Commission (EC), the proportion of EU-27 inhabitants over the age of 80 will increase from 5.8% to 14.6% between 2019 and 2100. Acute liver injury is more likely to occur in older people and is also more susceptible to the fibrotic response. Patients with the liver disease usually develop coagulopathy, making prothrombin complex concentrate an extremely efficient treatment. Researchers from the Royal Free Hospital in London and University College London discovered that PCC therapy improved coagulation test results in individuals with liver illness without causing an excessive number of thrombotic events in a 2019 study they conducted. The effectiveness of PCC treatments and an increase in the number of elderly people will improve the market's prospects in Europe.

As the use of oral anticoagulants and warfarin has greatly expanded, the emergence of anticoagulation care clinics has entered a phase of the treatment of bleeding disorders. The concept of warfarin clinics is gaining popularity in affluent countries of Europe. Owing to the notable variations in intrapatient & interpatient responses during warfarin administration, as well as the availability of skilled medical personnel and well-equipped infrastructure.

Acquired Coagulation Factor Accounted For The Largest Market Share in Terms of Application


Application-wise, the acquired coagulation factor deficiency market sector is anticipated to develop at the fastest CAGR and hold dominance. Warfarin prescription rates in the U.K. are rising, and defined guidelines for PCC dose schedules in the event of warfarin-related bleeding events are projected to support this segment's growth during the projection period. For instance, according to study results published by the National Center of Biotechnology Information (NCBI) in the UK, it has been discovered that at least 1% of the general population and 8% of persons over the age of 80 take warfarin. The acquired coagulation factor deficiency market is also anticipated to show promising growth over the forecast period.

Germany and France Anticipated to Lead the Europe Prothrombin Complex Concentrate Market


On the basis of country, the Europe prothrombin complex concentrate market is divided into Germany, the United Kingdom, Italy, France, The Netherlands, Belgium, Russia, Spain, Poland, Portugal, Austria, and the Rest of Europe. Germany and France are anticipated to lead the Europe PCC market due to a sizable patient pool with congenital factor IX deficiency. On the other side, the U.K. is anticipated to grow at the fastest rate during the forecast period due to the country's rising prevalence of haemophilia B. This is expected to increase the adoption of PCC throughout Europe. The PCC market in the rest of europe is expanding due to CSL Behring's PCC brand Confidex's established operations there and its use to treat both acquired and congenital coagulation factor deficiency. The high demand for the Uman Complex D.I., a 3-factor PCC by Kendrion, in Italy, the rise in bleeding disorders, and the dominance of large PCC producers all have an impact on the chance that France and Italy will develop at a consistent rate.

Impact of COVID-19 on Europe Prothrombin Complex Concentrate Market


The COVID-19 outbreak had no noticeable effect on expanding the prothrombin complex concentrate market. The demand for blood and plasma products has abruptly increased due to the COVID-19 pandemic. According to major PCC manufacturers, the prothrombin complex concentrate market has been favored by changes in the purchasing habits of plasma-derived products. Due to higher plasma center productivity and Kcentra's double-digit growth, pharmaceutical companies like Grifols and CSL are also experiencing an increase in segmental revenue. On the market as a whole, this is anticipated to have a favorable effect on Europe prothrombin complex concentrate market.

Competitive Landscape


The Europe prothrombin complex concentrate market is fragmented, with numerous players serving the market. The key players dominating in the Europe region are CSL Behring GmbH, OCTA Pharma AG, Kedrion S.P.A., Takeda Pharmaceuticals, China Biologic Products, Sanquin, Grifols S.A, Biotest, Abeona Therapeutics, Insud Pharma and Other Prominent Players. Facilities growth, product diversification, alliances, collaborations, partnerships, and acquisition are the main marketing strategies used by the players to increase their customer base and acquire a competitive advantage in the overall market.

Don’t miss the business opportunity in the Europe Prothrombin Complex Concentrate market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and statistics of the Europe Prothrombin Complex Concentrate market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Europe Prothrombin Complex Concentrate market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the market's growth drivers, challenges, and competitive dynamics.


This product will be delivered within 2 business days.

Table of Contents

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Europe Prothrombin Complex Concentrate Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Europe Prothrombin Complex Concentrate Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.1.1. 3-Factor
5.2.1.2. 4-Factor
5.2.2. By End-User
5.2.2.1. Hospital
5.2.2.2. Ambulatory Services
5.2.2.3. Others
5.2.3. By Application
5.2.3.1. Acquired Coagulation Factor Deficiency
5.2.3.2. Congenital Coagulation Factor Deficiency
5.2.3.3. Others
5.2.4. By Country
5.2.4.1. Germany
5.2.4.2. United Kingdom
5.2.4.3. Italy
5.2.4.4. France
5.2.4.5. Spain
5.2.4.6. The Netherlands
5.2.4.7. Belgium
5.2.4.8. Russia
5.2.4.9. Poland
5.2.4.10. Portugal
5.2.4.11. Austria
5.2.4.12. Rest of Europe
6. Germany Prothrombin Complex Concentrate Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End-User
6.2.3. By Application
7. United Kingdom Prothrombin Complex Concentrate Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End-User
7.2.3. By Application
8. Italy Prothrombin Complex Concentrate Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End-User
8.2.3. By Application
9. France Prothrombin Complex Concentrate Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End-User
9.2.3. By Application
10. Spain Prothrombin Complex Concentrate Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End-User
10.2.3. By Application
11. The Netherlands Prothrombin Complex Concentrate Market
11.1. Market Size & Forecast by Value, 2018-2028
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By End-User
11.2.3. By Application
12. Belgium Prothrombin Complex Concentrate Market
12.1. Market Size & Forecast by Value, 2018-2028
12.1.1. By Value (USD Million)
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By End-User
12.2.3. By Application
13. Russia Prothrombin Complex Concentrate Market
13.1. Market Size & Forecast by Value, 2018-2028
13.1.1. By Value (USD Million)
13.2. Market Share & Forecast
13.2.1. By Type
13.2.2. By End-User
13.2.3. By Application
14. Poland Prothrombin Complex Concentrate Market
14.1. Market Size & Forecast by Value, 2018-2028
14.1.1. By Value (USD Million)
14.2. Market Share & Forecast
14.2.1. By Type
14.2.2. By End-User
14.2.3. By Application
15. Portugal Prothrombin Complex Concentrate Market
15.1. Market Size & Forecast by Value, 2018-2028
15.1.1. By Value (USD Million)
15.2. Market Share & Forecast
15.2.1. By Type
15.2.2. By End-User
15.2.3. By Application
16. Austria Prothrombin Complex Concentrate Market
16.1. Market Size & Forecast by Value, 2018-2028
16.1.1. By Value (USD Million)
16.2. Market Share & Forecast
16.2.1. By Type
16.2.2. By End-User
16.2.3. By Application
17. Rest of the Europe Prothrombin Complex Concentrate Market
17.1. Market Size & Forecast by Value, 2018-2028
17.1.1. By Value (USD Million)
17.2. Market Share & Forecast
17.2.1. By Type
17.2.2. By End-User
17.2.3. By Application
18. Competitive Landscape
18.1. List of Key Players and Their Offerings
18.2. Market Share Analysis, 2021
18.3. Competitive Benchmarking, By Operating Parameters
18.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
19. Impact of COVID-19 on Europe Prothrombin Complex Concentrate Market
20. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
20.1. CSL Behring GmbH
20.2. OCTA Pharma AG
20.3. Kedrion S.P.A.
20.4. Takeda Pharmaceuticals
20.5. China Biologic Products
20.6. Sanquin
20.7. Grifols S.A
20.8. Biotest
20.9. Abeona Therapeutics
20.10. Insud Pharma
20.11. Other Prominent Players
21. Key Strategic Recommendations
List Of Figures
Figure 1: Europe Prothrombin Complex Concentrate Market Segmentation
Figure 2: Europe Prothrombin Complex Concentrate Market Industry Value Chain Analysis
Figure 3: Europe Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 4: Europe Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 5: Europe Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 6: Europe Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 7: Europe Prothrombin Complex Concentrate Market Share (%), By Country, By Value, 2018-2028
Figure 8: Germany Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 9: Germany Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 10: Germany Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 11: Germany Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 12: United Kingdom Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 13: United Kingdom Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 14: United Kingdom Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 15: United Kingdom Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 16: Italy Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 17: Italy Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 18: Italy Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 19: Italy Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 20: France Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 21: France Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 22: France Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 23: France Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 24: Spain Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 25: Spain Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 26: Spain Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 27: Spain Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 28: The Netherlands Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 29: The Netherlands Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 30: The Netherlands Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 31: The Netherlands Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 32: Belgium Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 33: Belgium Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 34: Belgium Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 35: Belgium Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 36: Russia Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 37: Russia Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 38: Russia Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 39: Russia Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 40: Poland Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 41: Poland Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 42: Poland Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 43: Poland Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 44: Portugal Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 45: Portugal Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 46: Portugal Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 47: Portugal Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 48: Austria Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 49: Austria Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 50: Austria Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 51: Austria Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 52: Rest of the Europe Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
Figure 53: Rest of the Europe Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
Figure 54: Rest of the Europe Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
Figure 55: Rest of the Europe Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
Figure 56: Europe Prothrombin Complex Concentrate Market Share Analysis, 2021
List Of Tables
Table 1: Europe Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 2: Europe Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 3: Europe Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 4: Europe Prothrombin Complex Concentrate Market Size. By Region, By Value (USD Million), 2018-2028
Table 5: Germany Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 6: Germany Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 7: Germany Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 8: United Kingdom Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 9: United Kingdom Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 10: United Kingdom Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 11: Italy Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 12: Italy Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 13: Italy Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 14: France Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 15: France Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 16: France Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 17: Spain Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 18: Spain Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 19: Spain Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 20: The Netherlands Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 21: The Netherlands Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 22: The Netherlands Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 23: Belgium Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 24: Belgium Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 25: Belgium Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 26: Russia Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 27: Russia Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 28: Russia Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 29: Poland Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 30: Poland Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 31: Poland Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 32: Portugal Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 33: Portugal Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 34: Portugal Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 35: Austria Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 36: Austria Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 37: Austria Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 38: Rest of the Europe Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
Table 39: Rest of the Europe Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
Table 40: Rest of the Europe Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
Table 41: List of Key Players and Their Offerings
Table 42: Competitive Benchmarking, by Operating Parameters
Table 43: CSL Behring GmbH Company Overview
Table 44: CSL Behring GmbH Financial Overview
Table 45: OCTA Pharma AG Company Overview
Table 46: OCTA Pharma AG Financial Overview
Table 47: Kedrion S.P.A. Company Overview
Table 48: Kedrion S.P.A. Financial Overview
Table 49: Takeda Pharmaceuticals Company Overview
Table 50: Takeda Pharmaceuticals Financial Overview
Table 51: China Biologic Products Company Overview
Table 52: China Biologic Products Financial Overview
Table 53: Sanquin Company Overview
Table 54: Sanquin Financial Overview
Table 55: Grifols S.A company Overview
Table 56: Grifols S.A Financial Overview
Table 57: Biotest Company Overview
Table 58: Biotest Financial Overview
Table 59: Abeona Therapeutics Company Overview
Table 60: Abeona Therapeutics Financial Overview
Table 61: Insud Pharma Company Overview
Table 62: Insud Pharma Financial Overview

Methodology

Loading
LOADING...